September 18, 2023

Dr. Noureldein Wins "Best Poster" at International Symposium

At the inaugural Steno Diabetes Neuro Unit (SDNU) Symposium in Copenhagen, Denmark, Mohamed Noureldein, Ph.D., won "Best Poster," for his research about the role of oligodendrocytes in metabolic syndrome-related dementia.

Steno Diabetes Neuro Unit (SDNU) Symposium 2023 chose postdoctoral fellow Mohamed Noureldein, Ph.D., as the winner for "Best Poster" at their inaugural international meeting this year in Copenhagen, Denmark.

Titled "Dysfunction of the Neuroglial Lactate Shuttle in Metabolic Syndrome Contributing to Cognitive and Memory Impairment," the poster shared Dr. Noureldein's research that looked at the role of oligodendrocytes in metabolic syndrome-related dementia. So far, his research has confirmed this hypothesis.

Dr. Noureldein, flanked by Drs. Jorgen Rungby, head of translational Type 2 Diabetes Research at SDCC (left), and Birgitte Brock, head of research at SDCC (right)

"Dr. Noureldein's science has already proven to be not only innovative but transformative in the field of diabetes and brain health," explained Eva Feldman, M.D., Ph.D., James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology. He has an uncanny way of getting at the base underlying mechanism in a way that no one has been able to do so before."

It seems that the Steno Diabetes Neuro Unit agreed. They especially appreciated Dr. Noureldein's ability to relate his preclinical basic science findings to humans and clinical research in his poster pitch.

When asked about the award, Dr. Noureldein shared: "I feel honored that I won this award and I feel particularly happy because my basic science research was recognized by clinical researchers who appreciated the translational aspect of my work."

He also shared that this award opens new avenues to test his hypothesis in patients and clinical settings.  

"This work has a great potential for collaborations with other researchers and clinicians in the field which is great for my career," and the many suffering from Alzheimer's disease and dementia.


About the Steno Diabetes Neuro Unit (SDNU) Symposium:

"Cognitive impairment is increasingly recognized as a complication of diabetes and may negatively impact diabetes care. The etiology of cognitive dysfunction in diabetes is not fully understood, and no established treatment exists. Yet, some guidelines recommend cognitive screening of older adults with diabetes to individualize treatment regimens. No consensus exists on if and how to test cognitive function in either research or clinical settings. This meeting will start this debate and encourage all participants, younger and more senior, to take an active part in discussions. The meeting will include presentations from leading researchers in the field and give younger researchers the opportunity to present their work and broaden their international network.  "